DN-201782

N/A

Report date: 2025/01/26 16:35:18
NME

Base Information

Drug NameDN-201782
Drug Alias Nametransglutaminase 2 inhibitors (Daegu-Gyeongbuk Medical Innovation Foundation)DN-201782
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaegu-Gyeongbuk Medical Innovation Foundation
China Registration ClassN/A

Develop Information

Active CompaniesDaegu-Gyeongbuk Medical Innovation Foundation
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A